This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Top Gainers Technical Data -- Research On BGC Partners, Sarepta Therapeutics, TripAdvisor, And LiveDeal

Stocks in this article: BGCPLIVESRPTTRIP

LONDON, April 2, 2014 /PRNewswire/ --

The US markets saw a positive sentiment on Tuesday, April 01, 2014, with the NASDAQ Composite closing at 4,268.04, up 1.64%, the Dow Jones Industrial Average ending the session at 16,532.61, up 0.46% and the S&P 500 edging 0.70% higher to finish the trading session at 1,885.52. During the session, gains in the Consumer Discretionary, Information Technology, and Industrials sectors positively impacted the broader market. A number of stocks saw large movements, including BGC Partners Inc. (NASDAQ: BGCP), Sarepta Therapeutics Inc. (NASDAQ: SRPT), TripAdvisor Inc. (NASDAQ: TRIP) and LiveDeal Inc. (NASDAQ: LIVE). Free technical research on BGCP, SRPT, TRIP and LIVE can be downloaded upon signing up at: http://www.investor-edge.com/684-register Shares in BGC Partners Inc. surged 8.10%, finishing Tuesday's session at $7.07. The stock fluctuated between $6.62 and $7.08 during the session with a trading volume of 1.74 million shares as compared to a three months average volume of 1.15 million shares. Shares in BGC Partners Inc. have surged 10.64% in the previous three trading sessions, 16.86% in the last three months, and 16.86% on YTD basis. The S&P 500 Financial Sector Index mapped a gain of 0.38% during the trading session and the same has charted up 3.47% in the last one month. Furthermore, the stocks have a Relative Strength Index (RSI) of 43.67 and are trading above their 50-day and 200-day moving averages of $6.71 and $6.05, respectively. Sign up today to read free research on BGCP at: http://www.investor-edge.com/684-BGCP-02Apr2014.pdf On Tuesday, shares in Sarepta Therapeutics Inc.'s stock ended the session at $25.71, up 6.99%. A total of 0.90 million shares were traded as compared to a three months average volume of 1.64 million shares. During the session, the stock traded between $24.26 and $25.98. Sarepta Therapeutics Inc.'s shares have rallied 8.34% in the previous three trading sessions, 26.22% in the last three months and 26.22% on YTD basis. The S&P 500 Health Care Sector Index mapped a gain of 0.70% during the trading session, and the same has advanced 6.14% in the last three months. Further, the company' shares are trading below their 50-day and 200-day moving averages of $26.64 and $31.74, respectively. The stock has an RSI of 40.22. Sign up today to read free research on SRPT at: http://www.investor-edge.com/684-SRPT-02Apr2014.pdf TripAdvisor Inc.'s stock finished Tuesday's session at $95.55, up 5.48%. A total of 2.62 million shares were traded which is above the three months average volume of 2.10 million shares. The stock vacillated between $90.75 and $95.78 during the session. Shares in TripAdvisor Inc. have surged 6.23% in the previous three trading sessions, 15.36% in the last three months and 15.36% on YTD basis. The S&P 500 Consumer Discretionary Sector Index mapped a gain of 1.40% during the trading session, and the same has advanced 2.85% in the previous three trading sessions. Additionally, the stock is trading above its 50-day and 200-day moving averages of $92.79 and $80.07, respectively. The company shares have an RSI of 34.25. Sign up today to read free research on TRIP at: http://www.investor-edge.com/684-TRIP-02Apr2014.pdf LiveDeal Inc.'s stock closed Tuesday's session at $7.19, which is 5.12% higher than the previous day's closing price of $6.84. A total of 0.56 million shares were traded as compared to a three months average volume of 2.22 million shares. The stock oscillated between $6.86 and $7.37 during the trading session. Shares in LiveDeal Inc. have surged 5.89% in the previous three trading sessions and 441.96% on YTD basis, while the stock has declined 7.58% in the last one month. The S&P 500 Information Technology Sector Index mapped a gain of 1.32% during the trading session and 3.20% in the last three months. Moreover, the stock is trading above its 200-day moving average of $2.71. The stock has an RSI of 45.76. Sign up today to read free research on LIVE at: http://www.investor-edge.com/684-LIVE-02Apr2014.pdf =============== EDITOR'S NOTES: =============== 1. This is not company news. We are an independent source and our views do not reflect the companies mentioned. 2. Information in this release is fact checked and produced on a best efforts basis and reviewed by Nidhi Vatsal, a CFA charterholder. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below. 3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public. 4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.investor-edge.com. 5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.investor-edge.com. 6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.investor-edge.com for consideration. COMPLIANCE PROCEDURE Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Investor-edge. An outsourced research services provider represented by Nidhi Vatsal, CFA, has only reviewed the information provided by Investor-edge in this article or report according to the Procedures outlined by Investor-edge. Investor-edge is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be. NOT FINANCIAL ADVICE Investor-edge makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein. NO WARRANTY OR LIABILITY ASSUMED Investor-edge is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Investor-edge whatsoever for any direct, indirect or consequential loss arising from the use of this document. Investor-edge expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Investor-edge does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice. CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE Investor-Edge

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,719.00 +33.27 0.19%
S&P 500 2,052.75 +4.03 0.20%
NASDAQ 4,701.8670 +26.1550 0.56%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs